194 related articles for article (PubMed ID: 34074677)
1. ST8Sia6 Promotes Tumor Growth in Mice by Inhibiting Immune Responses.
Friedman DJ; Crotts SB; Shapiro MJ; Rajcula M; McCue S; Liu X; Khazaie K; Dong H; Shapiro VS
Cancer Immunol Res; 2021 Aug; 9(8):952-966. PubMed ID: 34074677
[TBL] [Abstract][Full Text] [Related]
2. Cutting Edge: Enhanced Antitumor Immunity in ST8Sia6 Knockout Mice.
Friedman DJ; Kizerwetter M; Belmonte P; Rajcula M; Theodore K; Kim Lee HS; Shapiro MJ; Dong H; Shapiro VS
J Immunol; 2022 Apr; 208(8):1845-1850. PubMed ID: 35379746
[TBL] [Abstract][Full Text] [Related]
3. Cutting Edge: ST8Sia6-Generated α-2,8-Disialic Acids Mitigate Hyperglycemia in Multiple Low-Dose Streptozotocin-Induced Diabetes.
Belmonte PJ; Shapiro MJ; Rajcula MJ; McCue SA; Shapiro VS
J Immunol; 2020 Jun; 204(12):3071-3076. PubMed ID: 32350083
[TBL] [Abstract][Full Text] [Related]
4. The α2,8-sialyltransferase 6 (St8sia6) localizes in the ER and enhances the anchorage-independent cell growth in cancer.
Hatanaka R; Araki E; Hane M; Go S; Wu D; Kitajima K; Sato C
Biochem Biophys Res Commun; 2022 Jun; 608():52-58. PubMed ID: 35390672
[TBL] [Abstract][Full Text] [Related]
5. Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer.
Läubli H; Pearce OM; Schwarz F; Siddiqui SS; Deng L; Stanczak MA; Deng L; Verhagen A; Secrest P; Lusk C; Schwartz AG; Varki NM; Bui JD; Varki A
Proc Natl Acad Sci U S A; 2014 Sep; 111(39):14211-6. PubMed ID: 25225409
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics Analyses Identify the Therapeutic Potential of ST8SIA6 for Colon Cancer.
Ko CY; Chu TH; Hsu CC; Chen HP; Huang SC; Chang CL; Tzou SJ; Chen TY; Lin CC; Shih PC; Lin CH; Chang CF; Lee YK
J Pers Med; 2022 Mar; 12(3):. PubMed ID: 35330401
[TBL] [Abstract][Full Text] [Related]
7. ST8SIA6-AS1 promotes hepatocellular carcinoma by absorbing miR-5195-3p to regulate HOXB6.
Li Y; Jiang A
Cancer Biol Ther; 2020 Jul; 21(7):647-655. PubMed ID: 32420798
[TBL] [Abstract][Full Text] [Related]
8. Probing the cis interactions of the inhibitory receptor Siglec-7 with alpha2,8-disialylated ligands on natural killer cells and other leukocytes using glycan-specific antibodies and by analysis of alpha2,8-sialyltransferase gene expression.
Avril T; North SJ; Haslam SM; Willison HJ; Crocker PR
J Leukoc Biol; 2006 Oct; 80(4):787-96. PubMed ID: 16857734
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA ST8SIA6-AS1 promotes cell proliferation and metastasis in triple-negative breast cancer by targeting miR-145-5p/CDCA3 to inactivate the p53/p21 signaling pathway.
Qiao Y; Wang B; Yan Y; Niu L
Environ Toxicol; 2022 Oct; 37(10):2398-2411. PubMed ID: 35730485
[TBL] [Abstract][Full Text] [Related]
10. ST8SIA6-AS1 promotes the development of hepatocellular carcinoma cells through miR-338-3p/NONO Axis.
Kuai J; Zheng L; Yi X; Liu Z; Qiu B; Lu Z; Jiang Y
Dig Liver Dis; 2021 Sep; 53(9):1192-1200. PubMed ID: 33722502
[TBL] [Abstract][Full Text] [Related]
11. LncRNA ST8SIA6-AS1 promotes proliferation, migration and invasion in breast cancer through the p38 MAPK signalling pathway.
Fang K; Hu C; Zhang X; Hou Y; Gao D; Guo Z; Li L
Carcinogenesis; 2020 Sep; 41(9):1273-1281. PubMed ID: 31784750
[TBL] [Abstract][Full Text] [Related]
12. α2,6-linked sialic acids on N-glycans modulate the adhesion of hepatocarcinoma cells to lymph nodes.
Wang S; Chen X; Wei A; Yu X; Niang B; Zhang J
Tumour Biol; 2015 Feb; 36(2):885-92. PubMed ID: 25304155
[TBL] [Abstract][Full Text] [Related]
13. Long-term DEHP/MEHP exposure promotes colorectal cancer stemness associated with glycosylation alterations.
Shih PC; Chen HP; Hsu CC; Lin CH; Ko CY; Hsueh CW; Huang CY; Chu TH; Wu CC; Ho YC; Nguyen NUN; Huang SC; Fang CC; Tzou SJ; Wu YJ; Chen TY; Chang CF; Lee YK
Environ Pollut; 2023 Jun; 327():121476. PubMed ID: 36997141
[TBL] [Abstract][Full Text] [Related]
14. Ganglioside GD3 expression on target cells can modulate NK cell cytotoxicity via siglec-7-dependent and -independent mechanisms.
Nicoll G; Avril T; Lock K; Furukawa K; Bovin N; Crocker PR
Eur J Immunol; 2003 Jun; 33(6):1642-8. PubMed ID: 12778482
[TBL] [Abstract][Full Text] [Related]
15. Limited impact of cancer-derived gangliosides on anti-tumor immunity in colorectal cancer.
van der Haar Àvila I; Zhang T; Lorrain V; de Bruin F; Spreij T; Nakayama H; Iwabuchi K; García-Vallejo JJ; Wuhrer M; van Kooyk Y; van Vliet SJ
Glycobiology; 2024 May; 34(7):. PubMed ID: 38785323
[TBL] [Abstract][Full Text] [Related]
16. The sialoglycan-Siglec glyco-immune checkpoint - a target for improving innate and adaptive anti-cancer immunity.
Bärenwaldt A; Läubli H
Expert Opin Ther Targets; 2019 Oct; 23(10):839-853. PubMed ID: 31524529
[No Abstract] [Full Text] [Related]
17. Linkage-specific action of endogenous sialic acid O-acetyltransferase in Chinese hamster ovary cells.
Shi WX; Chammas R; Varki A
J Biol Chem; 1996 Jun; 271(25):15130-8. PubMed ID: 8662976
[TBL] [Abstract][Full Text] [Related]
18. Profiling of specific long non-coding RNA signatures identifies ST8SIA6-AS1 AS a novel target for breast cancer.
Chen Z; Huang J; Feng Y; Li Z; Jiang Y
J Gene Med; 2021 Feb; 23(2):e3286. PubMed ID: 33037712
[TBL] [Abstract][Full Text] [Related]
19. Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9.
Rodriguez E; Boelaars K; Brown K; Eveline Li RJ; Kruijssen L; Bruijns SCM; van Ee T; Schetters STT; Crommentuijn MHW; van der Horst JC; van Grieken NCT; van Vliet SJ; Kazemier G; Giovannetti E; Garcia-Vallejo JJ; van Kooyk Y
Nat Commun; 2021 Feb; 12(1):1270. PubMed ID: 33627655
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the specificity of sialyltransferases toward mucin core 2, globo, and related structures. identification of the sialylation sequence and the effects of sulfate, fucose, methyl, and fluoro substituents of the carbohydrate chain in the biosynthesis of selectin and siglec ligands, and novel sialylation by cloned alpha2,3(O)sialyltransferase.
Chandrasekaran EV; Xue J; Xia J; Chawda R; Piskorz C; Locke RD; Neelamegham S; Matta KL
Biochemistry; 2005 Nov; 44(47):15619-35. PubMed ID: 16300412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
